Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Statins and Antimicrobial Effects: Simvastatin as a Potential Drug against Staphylococcus aureus Biofilm

Texto completo
Autor(es):
Graziano, Talita Signoreti [1] ; Cuzzullin, Maria Claudia [1] ; Franco, Gilson Cesar [2] ; Schwartz-Filho, Humberto Osvaldo [3] ; de Andrade, Eduardo Dias [1] ; Groppo, Francisco Carlos [1] ; Cogo-Mueller, Karina [1, 3]
Número total de Autores: 7
Afiliação do(s) autor(es):
[1] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Physiol Sci, Pharmacol Anesthesiol & Therapeut, Piracicaba, SP - Brazil
[2] Univ Estadual Ponta Grossa, Dept Gen Biol, Area Physiol & Pathophysiol, Ponta Grossa, Parana - Brazil
[3] Univ Santo Amaro, Dept Dent, Implantol Area, Sao Paulo, SP - Brazil
Número total de Afiliações: 3
Tipo de documento: Artigo Científico
Fonte: PLoS One; v. 10, n. 5 MAY 28 2015.
Citações Web of Science: 30
Resumo

Statins are important lipid-lowering agents with other pleiotropic effects. Several studies have explored a possible protective effect of statins to reduce the morbidity and mortality of many infectious diseases. Staphylococcus aureus is one of the main pathogens implicated in nosocomial infections; its ability to form biofilms makes treatment difficult. The present study observed the MIC of atorvastatin, pravastatin and simvastatin against S. aureus, Pseudomonas aeruginosa, Escherichia coli and Enterococcus faecalis. Simvastatin was the only agent with activity against clinical isolates and reference strains of methicilin-sensitive S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA). Thus, the effects of simvastatin on the growth, viability and biofilm formation of S. aureus were tested. In addition, a possible synergistic effect between simvastatin and vancomycin was evaluated. Simvastatin's MIC was 15.65 mu g/mL for S. aureus 29213 and 31.25 mu g/mL for the other strains of S. aureus. The effect of simvastatin was bactericidal at 4xMIC and bacteriostatic at the MIC concentration. No synergistic effect was found between simvastatin and vancomycin. However, the results obtained against S. aureus biofilms showed that, in addition to inhibiting adhesion and biofilm formation at concentrations from 1/16xMIC to 4xMIC, simvastatin was also able to act against mature biofilms, reducing cell viability and extra-polysaccharide production. In conclusion, simvastatin showed pronounced antimicrobial activity against S. aureus biofilms, reducing their formation and viability. (AU)

Processo FAPESP: 13/06570-3 - Análise dos efeitos das estatinas sobre a viabilidade bacteriana e formação de biofilme de microorganismos aeróbios patogênicos
Beneficiário:Karina Cogo Müller
Linha de fomento: Auxílio à Pesquisa - Regular
Processo FAPESP: 11/15795-3 - Análise dos efeitos das estatinas sobre a viabilidade bacteriana e formação de biofilme de microorganismos aeróbios patogênicos
Beneficiário:Talita Signoreti Graziano
Linha de fomento: Bolsas no Brasil - Mestrado